1.Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 2005. MMWR Recomm Rep 2005;54:1–141.
2.Sokolove, PE, Rossman, L, Cohen, SH. The emergency department presentation of patients with active pulmonary tuberculosis. Acad Emerg Med 2000;7:1056–1060.
3.Scott, B, Schmid, M, Nettleman, MD. Early identification and isolation of inpatients at high risk for tuberculosis. Arch Intern Med 1994;154:326–330.
4.Wisnivesky, J, Kaplan, J, Henschke, C, McGinn, TG, Crystal, RG. Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients. Arch Intern Med 2000;160:2471–2476.
5.Wisnivesky, J, Henschke, C, Balentine, J, Willner, C, Deloire, AM, McGinn, TG. Prospective validation of a prediction model for isolating inpatients with suspected pulmonary tuberculosis. Arch Intern Med 2005;165:453–457.
6.Pegues, C, Johnson, DC, Pegues, DA. Implementation and evaluation of an algorithm for isolation of patients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol 1996;17:412–418.
7.Bock, NN, McGowan, JE, Ahn, J. Clinical predictors of tuberculosis as a guide for a respiratory isolation policy. Am J Respir Crit Care Med 1996;154:1468–1472.
8.Knirsch, CA, Jain, NL, Pablos-Mendez, A, Friedman, C, Hripcsak, G. Respiratory isolation of tuberculosis patients using clinical guidelines and an automated clinical decision support system. Infect Control Hosp Epidemiol 1998;19:94–100.
9.Tattevin, P, Casalino, E, Fleury, L, Egmann, G, Ruel, M, Bouvet, E. The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis. Chest 1999;115:1248–1253.
10.Centers for Disease Control and Prevention (CDC). Reported tuberculosis in the United States, 2006. Atlanta, GA: US Department of Health and Human Services, CDC; September 2007.
11.Cohen, R, Muzaffar, S, Capellan, J, Azar, H, Chinikamwala, M. The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis. Chest 1996;109:420–512.
12.Randolph, AG, Guyatt, GH, Calvin, JE, et al.Understanding articles describing clinical prediction tools. Crit Care Med 1998;26:1603–1612.
13.Slovis, BS, Plitman, JD. The case against anergy testing as a routine adjunct to tuberculin skin testing. JAMA 2000;283:2003–2007.
14.Poduval, RD, Hammes, MS. Tuberculosis screening in dialysis patients—is the tuberculin test effective? Clinical Nephrology 2003;59:436–440.
15.American Thoracic Society (ATS). ATS guidelines: diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376–1395.
16.Wolfe, F, Michaud, K, Anderson, J, Urbansky, K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 2004;50:372–379.
17.Gomez-Reino, JJ, Carmona, L, Valverde, VR, Mola, EM, Montero, MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 2003;48:2122–2127.
18.Feingold, AO. Association of tuberculosis with alcoholism. South Med J 1976;69:1336–1337.
19.Friedman, LN, Sullivan, GM, Bevilaqua, RP, Loscos, R. Tuberculosis screening in alcoholics and drug addicted. Am Rev Resp Dis 1987;136:1188–1192.
20.Macgregor, RR. Alcohol and immune defense. JAMA 1986;256:1474–1479.
21.Pitchenik, AE, Rubinson, HA. Radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome. Am Rev Respir Dis 1985;131:393–396.
22.Cobo, J, Oliva, J, Asensio, A, et al.Predicting tuberculosis among HIV-infected patients admitted to hospital: comparison of a model with clinical judgment of infectious diseases specialists. Eur J Clin Microbiol Infect Dis 2001;20:779–784.